Skip to main content
Top
Published in: BMC Anesthesiology 1/2014

Open Access 01-12-2014 | Research article

Can serum L-lactate, D-lactate, creatine kinase and I-FABP be used as diagnostic markers in critically ill patients suspected for bowel ischemia

Authors: Peter HJ van der Voort, Berit Westra, Jos PJ Wester, Rob J Bosman, Ilse van Stijn, Inez-Anne Haagen, Ference J Loupatty, Saskia Rijkenberg

Published in: BMC Anesthesiology | Issue 1/2014

Login to get access

Abstract

Background

The prognostic value of biochemical tests in critically ill patients with multiple organ failure and suspected bowel ischemia is unknown.

Methods

In a prospective observational cohort study intensive care patients were included when the attending intensivist considered intestinal ischemia in the diagnostic workup at any time during intensive care stay. Patients were only included once. When enrolment was ended each patient was classified as ‘proven intestinal ischemia’, ‘ischemia likely’, ‘ischemia unlikely’ or ‘no intestinal ischemia’. Proven intestinal ischemia was defined as the gross disturbance of blood flow in the bowel, regardless of extent and grade. Classification was based on reports from the operating surgeon, pathology department, endoscopy reports and CT-scan. Lactate dehydrogenase (LDH), creatine kinase (CK), alanine aminotransferase (ALAT), L-lactate were available for the attending physician. D-lactate and intestinal fatty acid binding protein (I-FABP) were analysed later in a batch. I-FABP was only measured in patients with proven ischemia or no ischemia.

Results

For 44 of the 120 included patients definite diagnostic studies were available. 23/44 patients (52%) had proven intestinal ischemia as confirmed by surgery, colonoscopy, autopsy and/or histopathological findings. LDH in these patients was 285 U/l (217–785) vs 287 U/l (189–836) in no-ischemia; p = 0.72. CK was 226 U/l in patients with proven ischemia (126–2145) vs 347 U/l (50–1427), p = 0.88. ALAT was 53 U/l (18–300) vs 34 U/l (14–34), p-0,56. D-lactate 0.41 mmol/l (0.11-0.75) vs 0.56 mmol/l (0.27-0.77), p = 0.46. L-lactate 3.5 mmol/l (2.2-8.4) vs 2.6 mmol/l (1.7-3.9), p = 0.09. I-FABP 2872 pg/ml (229–4340) vs 1020 pg/ml (239–5324), p = 0.98. Patient groups proven and likely ischemia together compared to unlikely and no-ischemia together showed significant higher L-lactate (p = 0.001) and higher D-lactate (p = 0.003).

Conclusions

Measurement of LDH, CK, and ALAT did not discriminate critically ill patients with proven intestinal ischemia from those with definite diagnosis no-ischemia. However, L-lactate and D-lactate levels were higher in patients with proven or likely ischemia and need further study just as I-FABP.
Appendix
Available only for authorised users
Literature
1.
go back to reference Acosta S: Epidemiology of mesenteric vascular disease: clinical implications. Semin Vasc Surg. 2010, 23: 4-8. 10.1053/j.semvascsurg.2009.12.001.CrossRefPubMed Acosta S: Epidemiology of mesenteric vascular disease: clinical implications. Semin Vasc Surg. 2010, 23: 4-8. 10.1053/j.semvascsurg.2009.12.001.CrossRefPubMed
2.
go back to reference Nilsson J, Hansson E, Andersson B: Intestinal ischemia after cardiac surgery: analysis of a large registry. J Cardiothorac Surg. 2013, 8: 156-10.1186/1749-8090-8-156.CrossRefPubMedPubMedCentral Nilsson J, Hansson E, Andersson B: Intestinal ischemia after cardiac surgery: analysis of a large registry. J Cardiothorac Surg. 2013, 8: 156-10.1186/1749-8090-8-156.CrossRefPubMedPubMedCentral
3.
go back to reference Björck M, Wanhainen A: Nonocclusive mesenteric hypoperfusion syndromes: recognition and treatment. Semin Vasc Surg. 2010, 23: 54-64. 10.1053/j.semvascsurg.2009.12.009.CrossRefPubMed Björck M, Wanhainen A: Nonocclusive mesenteric hypoperfusion syndromes: recognition and treatment. Semin Vasc Surg. 2010, 23: 54-64. 10.1053/j.semvascsurg.2009.12.009.CrossRefPubMed
4.
go back to reference Howard TJ, Plaskon LA, Wiebke EA, Wilcox MG, Madura JA: Non-occlusive mesenteric ischemia remains a diagnostic dilemma. Am J Surg. 1996, 171: 405-408. 10.1016/S0002-9610(97)89619-5.CrossRefPubMed Howard TJ, Plaskon LA, Wiebke EA, Wilcox MG, Madura JA: Non-occlusive mesenteric ischemia remains a diagnostic dilemma. Am J Surg. 1996, 171: 405-408. 10.1016/S0002-9610(97)89619-5.CrossRefPubMed
5.
go back to reference Demir IE, Ceyhan GO, Friess H: Beyond lactate: is there a role for serum lactate measurement in diagnosing acute mesenteric ischemia?. Dig Surg. 2012, 29: 226-235. 10.1159/000338086.CrossRefPubMed Demir IE, Ceyhan GO, Friess H: Beyond lactate: is there a role for serum lactate measurement in diagnosing acute mesenteric ischemia?. Dig Surg. 2012, 29: 226-235. 10.1159/000338086.CrossRefPubMed
6.
go back to reference Poeze M, Froon AHM, Greve JWM, Ramsay G: D-lactate as an early marker of intestinal ischaemia after ruptured abdominal aortic aneurysm repair. Br J Surg. 1998, 85: 1221-1224. 10.1046/j.1365-2168.1998.00837.x.CrossRefPubMed Poeze M, Froon AHM, Greve JWM, Ramsay G: D-lactate as an early marker of intestinal ischaemia after ruptured abdominal aortic aneurysm repair. Br J Surg. 1998, 85: 1221-1224. 10.1046/j.1365-2168.1998.00837.x.CrossRefPubMed
7.
go back to reference Murray MJ, Gonze MD, Nowak LR, Cobb CF: Serum D-lactate levels as an aid to diagnosing acute intestinal ischemia. Am J Surg. 1994, 167: 575-578. 10.1016/0002-9610(94)90101-5.CrossRefPubMed Murray MJ, Gonze MD, Nowak LR, Cobb CF: Serum D-lactate levels as an aid to diagnosing acute intestinal ischemia. Am J Surg. 1994, 167: 575-578. 10.1016/0002-9610(94)90101-5.CrossRefPubMed
8.
go back to reference Assadian A, Assadian O, Senekowitsch C, Rotter R, Bahrami S, Fürst W, Jaksch W, Hagmüller GW, Hübl W: Plasma D-lactate as a potential early marker for colon ischaemia after open aortic reconstruction. Eur J Vasc Endovasc Surg. 2006, 31: 470-474. 10.1016/j.ejvs.2005.10.031.CrossRefPubMed Assadian A, Assadian O, Senekowitsch C, Rotter R, Bahrami S, Fürst W, Jaksch W, Hagmüller GW, Hübl W: Plasma D-lactate as a potential early marker for colon ischaemia after open aortic reconstruction. Eur J Vasc Endovasc Surg. 2006, 31: 470-474. 10.1016/j.ejvs.2005.10.031.CrossRefPubMed
9.
go back to reference Kanda T, Tsukahara A, Ueki K, Sakai Y, Tani T, Nishimura A, Yamanzaki T, Tamiya Y, Tada T, Hirota M, Hasegawa J, Funaoka H, Fujii H, Hatakeyama K: Diagnosis of ischemic small bowel disease by measurement of serum intestinal fatty acid-binding protein in patients with acute abdomen: a multicenter, observer-blinded validation study. J Gastroenterol. 2011, 46: 492-500. 10.1007/s00535-011-0373-2.CrossRefPubMed Kanda T, Tsukahara A, Ueki K, Sakai Y, Tani T, Nishimura A, Yamanzaki T, Tamiya Y, Tada T, Hirota M, Hasegawa J, Funaoka H, Fujii H, Hatakeyama K: Diagnosis of ischemic small bowel disease by measurement of serum intestinal fatty acid-binding protein in patients with acute abdomen: a multicenter, observer-blinded validation study. J Gastroenterol. 2011, 46: 492-500. 10.1007/s00535-011-0373-2.CrossRefPubMed
10.
go back to reference Lieberman JM, Sacchettini J, Marks C, Marks WH: Human intestinal fatty acid binding protein: report of an assay with studies in normal volunteers and intestinal ischemia. Surgery. 1997, 121: 335-342. 10.1016/S0039-6060(97)90363-9.CrossRefPubMed Lieberman JM, Sacchettini J, Marks C, Marks WH: Human intestinal fatty acid binding protein: report of an assay with studies in normal volunteers and intestinal ischemia. Surgery. 1997, 121: 335-342. 10.1016/S0039-6060(97)90363-9.CrossRefPubMed
11.
go back to reference Cronk DR, Houseworth TP, Cuadrado DG, Herbert GS, McNutt PM, Azarow KS: Intestinal fatty acid binding protein (I-FABP) for the detection of strangulated mechanical small bowel obstruction. Curr Surg. 2006, 63: 322-325. 10.1016/j.cursur.2006.05.006.CrossRefPubMed Cronk DR, Houseworth TP, Cuadrado DG, Herbert GS, McNutt PM, Azarow KS: Intestinal fatty acid binding protein (I-FABP) for the detection of strangulated mechanical small bowel obstruction. Curr Surg. 2006, 63: 322-325. 10.1016/j.cursur.2006.05.006.CrossRefPubMed
12.
go back to reference Sonnino R, Eroso G, Arcuni J, Franson R: Human intestinal fatty acid binding protein in peritoneal fluid is a marker of intestinal ischemia. Transplant Proc. 2000, 32: 1280-10.1016/S0041-1345(00)01225-2.CrossRefPubMed Sonnino R, Eroso G, Arcuni J, Franson R: Human intestinal fatty acid binding protein in peritoneal fluid is a marker of intestinal ischemia. Transplant Proc. 2000, 32: 1280-10.1016/S0041-1345(00)01225-2.CrossRefPubMed
13.
go back to reference Camkiran A, Donmez A, Aldemir D, Isqüzar RA, Gültekin B: Clinical significance of intestinal type fatty acid binding protein in patients undergoing coronary artery bypass surgery. Anadolu Kardiyol Derg. 2011, 11: 536-541.PubMed Camkiran A, Donmez A, Aldemir D, Isqüzar RA, Gültekin B: Clinical significance of intestinal type fatty acid binding protein in patients undergoing coronary artery bypass surgery. Anadolu Kardiyol Derg. 2011, 11: 536-541.PubMed
14.
go back to reference Kanda T, Nakatomi Y, Ishikawa H, Hitomi M, Matsubara Y, Ono T, Muto T: Intestnial fatty acid-binding protein as a sensitive marker of intestinal ischemia. Dig Dis Sci. 1992, 37: 1362-1367. 10.1007/BF01296004.CrossRefPubMed Kanda T, Nakatomi Y, Ishikawa H, Hitomi M, Matsubara Y, Ono T, Muto T: Intestnial fatty acid-binding protein as a sensitive marker of intestinal ischemia. Dig Dis Sci. 1992, 37: 1362-1367. 10.1007/BF01296004.CrossRefPubMed
15.
go back to reference Gollin G, Marks C, Marks WH: Intestinal fatty acid binding protein in serum and urine reflects early ischemic injury to the small bowel. Surgery. 1993, 113: 545-551.PubMed Gollin G, Marks C, Marks WH: Intestinal fatty acid binding protein in serum and urine reflects early ischemic injury to the small bowel. Surgery. 1993, 113: 545-551.PubMed
16.
go back to reference Kanda T, Fujii H, Tani T, Murakami H, Suda T, Sakai Y, Ono T, Hatakeyama K: Intestinal fatty acid-binding protein is a useful diagnostic marker for mesenteric infarction in humans. Gastroenterology. 1996, 110: 339-343. 10.1053/gast.1996.v110.pm8566578.CrossRefPubMed Kanda T, Fujii H, Tani T, Murakami H, Suda T, Sakai Y, Ono T, Hatakeyama K: Intestinal fatty acid-binding protein is a useful diagnostic marker for mesenteric infarction in humans. Gastroenterology. 1996, 110: 339-343. 10.1053/gast.1996.v110.pm8566578.CrossRefPubMed
17.
go back to reference Kanda T, Fujii H, Fujita M, Sakai Y, Ono T, Hatakeyama K: Intestinal fatty acid binding protein is available for the diagnosis of intestinal ischemia; immunochemical analysis of two patients with ischaemic intestinal diseases. Gut. 1995, 36: 788-791. 10.1136/gut.36.5.788.CrossRefPubMedPubMedCentral Kanda T, Fujii H, Fujita M, Sakai Y, Ono T, Hatakeyama K: Intestinal fatty acid binding protein is available for the diagnosis of intestinal ischemia; immunochemical analysis of two patients with ischaemic intestinal diseases. Gut. 1995, 36: 788-791. 10.1136/gut.36.5.788.CrossRefPubMedPubMedCentral
18.
go back to reference Menon NJ, Amin AM, Mohammed A, Hamilton G: Acute mesenteric ischaemia. Acta Chir Belg. 2005, 105: 344-354.CrossRefPubMed Menon NJ, Amin AM, Mohammed A, Hamilton G: Acute mesenteric ischaemia. Acta Chir Belg. 2005, 105: 344-354.CrossRefPubMed
19.
go back to reference Herrera DJ, Morris K, Johnston C, Griffiths P: Automated assay for plasma D-lactate by enzymatic spectrophotometric analysis with sample blank correction. Ann Clin Biochem. 2008, 45: 177-183. 10.1258/acb.2007.007088.CrossRefPubMed Herrera DJ, Morris K, Johnston C, Griffiths P: Automated assay for plasma D-lactate by enzymatic spectrophotometric analysis with sample blank correction. Ann Clin Biochem. 2008, 45: 177-183. 10.1258/acb.2007.007088.CrossRefPubMed
20.
go back to reference Thuijls G, van Wijck K, Grootjans J, Derikx JPM, van Bijnen AA, Heineman E, Dejong CHC, Buurman WA, Poeze M: Early diagnosis of intestinal ischemia using urinary and plasma fatty acid binding proteins. Ann Surg. 2011, 253: 302-308.CrossRef Thuijls G, van Wijck K, Grootjans J, Derikx JPM, van Bijnen AA, Heineman E, Dejong CHC, Buurman WA, Poeze M: Early diagnosis of intestinal ischemia using urinary and plasma fatty acid binding proteins. Ann Surg. 2011, 253: 302-308.CrossRef
21.
go back to reference Vermeulen Windsant IC, Hellenthal FA, Derikx JP, Prins MH, Buurman WA, Jacobs MJ, Schurink GW: Circulating intestinal fatty acid-binding protein as an early marker of intestinal necrosis after aortic surgery: a prospective observational cohort study. Ann Surg. 2012, 255: 796-803. 10.1097/SLA.0b013e31824b1e16.CrossRefPubMed Vermeulen Windsant IC, Hellenthal FA, Derikx JP, Prins MH, Buurman WA, Jacobs MJ, Schurink GW: Circulating intestinal fatty acid-binding protein as an early marker of intestinal necrosis after aortic surgery: a prospective observational cohort study. Ann Surg. 2012, 255: 796-803. 10.1097/SLA.0b013e31824b1e16.CrossRefPubMed
22.
go back to reference Block T, Nilsson TK, Björck M, Acosta S: Diagnostic accuracy of plasma biomarkers for intestinal ischaemia. Scand J Clin Lab Invest. 2008, 68: 242-248. 10.1080/00365510701646264.CrossRefPubMed Block T, Nilsson TK, Björck M, Acosta S: Diagnostic accuracy of plasma biomarkers for intestinal ischaemia. Scand J Clin Lab Invest. 2008, 68: 242-248. 10.1080/00365510701646264.CrossRefPubMed
23.
go back to reference Collange O, Tamion F, Meyer N, Quillard M, Kindo M, Hue G, Veber B, Dureuil B, Plissonnier D: Early detection of gut ischemia-reperfusion injury during aortic abdominal aneurysmectomy: a pilot observational study. J Cardiothorac Vasc Anesth. 2013, 27: 690-695. 10.1053/j.jvca.2013.01.018.CrossRefPubMed Collange O, Tamion F, Meyer N, Quillard M, Kindo M, Hue G, Veber B, Dureuil B, Plissonnier D: Early detection of gut ischemia-reperfusion injury during aortic abdominal aneurysmectomy: a pilot observational study. J Cardiothorac Vasc Anesth. 2013, 27: 690-695. 10.1053/j.jvca.2013.01.018.CrossRefPubMed
24.
go back to reference Troseid M, Lind A, Nowak P, Barqasho B, Heger B, Lygren I, Pedersen K, Kanda T, Funaoka H, Damås J, Kvale D: Circulating levels of HMGB1 are correlated strongly with MD2 in HIV-infection: possible implication for TLR4-signalling and chronic immune activation. Innate Immun. 2013, 19: 290-297. 10.1177/1753425912461042.CrossRefPubMed Troseid M, Lind A, Nowak P, Barqasho B, Heger B, Lygren I, Pedersen K, Kanda T, Funaoka H, Damås J, Kvale D: Circulating levels of HMGB1 are correlated strongly with MD2 in HIV-infection: possible implication for TLR4-signalling and chronic immune activation. Innate Immun. 2013, 19: 290-297. 10.1177/1753425912461042.CrossRefPubMed
Metadata
Title
Can serum L-lactate, D-lactate, creatine kinase and I-FABP be used as diagnostic markers in critically ill patients suspected for bowel ischemia
Authors
Peter HJ van der Voort
Berit Westra
Jos PJ Wester
Rob J Bosman
Ilse van Stijn
Inez-Anne Haagen
Ference J Loupatty
Saskia Rijkenberg
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Anesthesiology / Issue 1/2014
Electronic ISSN: 1471-2253
DOI
https://doi.org/10.1186/1471-2253-14-111

Other articles of this Issue 1/2014

BMC Anesthesiology 1/2014 Go to the issue